logo

Enter Symbol

Blog Articles for CLDA
Mike Havrilla image
BioMed Research Reports: Clinical Data (NASDAQ: CLDA), Lpath (OTC: LPTN.OB)
By: Mike Havrilla
Publish Date: Friday, November 27, 2009
Stocks(s): CLDA, CRL, LPTN, SUP
Sector(s): Medical

Mike Havrilla image
Celldex Therapeutics (NASDAQ: CLDX): Plenty of Cash and Pending Clinical Catalysts
By: Mike Havrilla
Publish Date: Monday, October 19, 2009
Stocks(s): ASCO, BMY, CLDA, CRGN, ETEC, GBM, GSK, MEDX

Mike Havrilla image
FDA Calendar Extreme Trades: 85 Single Digit Stocks
By: Mike Havrilla
Publish Date: Tuesday, October 13, 2009
Stocks(s): ACCP, APOL, CFS, CLDA, CRI, CRL, CYTX, DCTH
Sector(s): Medical

Mike Havrilla image
10 Extreme Trades On Pending Clinical Trial Results
By: Mike Havrilla
Publish Date: Thursday, May 14, 2009
Stocks(s): ARNA, AVNR, CLDA, FOLD, GNTA, INSM, JAZZ, OREX
Sector(s): Medical

TraderMark image
How One Reader Found Dendreon (DNDN)
By: TraderMark
Publish Date: Tuesday, April 21, 2009
Stocks(s): CLDA, DNDN, MRK
Sector(s): Finance

Bullish Bankers image
Healthcare Product And Supplies, Short And Long Term Outlook
By: Bullish Bankers
Publish Date: Monday, April 06, 2009
Stocks(s): ABT, ACL, BDX, BSX, CLDA, CYNO, HCP, JNJ
Sector(s): Medical

Ohad Hammer image
Spicing Up The Biotech Portfolio - Curagen and Curis
By: Ohad Hammer
Publish Date: Tuesday, February 24, 2009
Stocks(s): CLDA, CRGN, CRIS, CRXL, DNA, NVS, SGEN, THLD
Sector(s): Medical

Zacks Investment Research image
AMAG Pharma: High Expectations - Analyst Blog
By: Zacks Investment Research
Publish Date: Tuesday, January 20, 2009
Stocks(s): AMAG, CLDA
Sector(s): Medical

Zacks Investment Research image
Cytori Therapeutics' Big Upside - Analyst Blog
By: Zacks Investment Research
Publish Date: Tuesday, November 11, 2008
Stocks(s): CLDA, CYTX
Sector(s): Medical

Zacks Investment Research image
Amag Pharma a Magnificent Buy - Analyst Blog
By: Zacks Investment Research
Publish Date: Tuesday, November 04, 2008
Stocks(s): AMAG, CLDA
Sector(s): Medical

Ohad Hammer image
Arqule’s Imminent Licensing Deal
By: Ohad Hammer
Publish Date: Thursday, October 02, 2008
Stocks(s): AIG, AMGN, ARQL, CLDA, DNA, EXEL, GSK, JNJ
Sector(s): Finance, Medical



Zacks Investment Research image
Micromet No Longer a Buy
By: Zacks Investment Research
Publish Date: Thursday, August 28, 2008
Stocks(s): CLDA, MITI
Sector(s): Medical

Ohad Hammer image
Another Seal of Approval For Micromet
By: Ohad Hammer
Publish Date: Tuesday, August 19, 2008
Stocks(s): AZN, CLDA, IMGN, MEDI, MITI, SNY
Sector(s): Medical


Ohad Hammer image
Poniard Pharmaceuticals– Platinum Rediscovered (Part I)
By: Ohad Hammer
Publish Date: Thursday, May 29, 2008
Stocks(s): ASCO, AZN, BBI, CLDA, DNA, PARD, SNY, SPPI
Sector(s): Medical

Ohad Hammer image
Immunogen and Seattle Genetics – On The Verge Of An Inflection Point
By: Ohad Hammer
Publish Date: Saturday, May 24, 2008
Stocks(s): ADC, ASCO, CLDA, CRGN, DNA, IMGN, MITI, SGEN
Sector(s): Finance, Medical

TraderMark image
Bookkeeping: Beginning Position in Schering-Plough (SGP)
By: TraderMark
Publish Date: Thursday, February 14, 2008
Stocks(s): CLDA, GILD, GS, ILMN, LDL, MRK, SGP
Sector(s): Medical

News Visual image
Biogen Idec Reports Very Healthy Q4 and Full-Year 2007 Earnings
By: News Visual
Publish Date: Wednesday, February 06, 2008
Stocks(s): BIIB, BSX, CLDA, HAE, MGRM, PKI, THRX
Sector(s): Computer and Technology, Medical

News Visual image
Biogen Reports Very Healthy Q4 and Full-Year 2007 Earnings
By: News Visual
Publish Date: Wednesday, February 06, 2008
Stocks(s): BIIB, BSX, CLDA, HAE, MGRM, PKI, THRX
Sector(s): Medical

Page 1 of 1
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia